Ceryx Medical raises £3.8m in seed funding to bring cardiac device to in-human trials
April 27, 2022
April 27, 2022
April 25, 2022
February 9, 2022
February 9, 2022
February 8, 2022
December 15, 2021
December 15, 2021
December 13, 2021
December 6, 2021
August 6, 2026
Tempus joins as a second commercial laboratory partnership to support oncology-focused access within CellCarta’s CDx Accelerator Model. CellCarta, a g...
July 22, 2026
Milestone marks the transition of Low Dose IL-2 from clinical development to a scalable, regulatory-ready commercial manufacturing process Strategic s...
July 20, 2026
New registration expands access to minimally invasive skin microbiopsy for clinical, research, and wellness applications. Trajan today announced the H...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225